The Pharma Report

  • News
  • About Us
    • Our Team
  • Consulting
    • Market Access, Pricing, and Reimbursement
    • HEOR
    • Value Messaging
    • Additional services
  • Database

FDA Drug Safety Information for November 19, 2024

Nov 192024
 
Date
Brand Name(s)
Description
Type
Reason
Company 
11/19/2024 Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (C-IV) Drugs Mislabeled with the incorrect strength on the carton Endo, Inc.

Sorry, the comment form is closed at this time.

  FDA Novel Drug Approvals – October 2024   FDA Drug Safety Information for November 21, 2024

The Pharma Report™ © 2010 - 2025 Stino LLC All Rights Reserved Suffusion theme by Sayontan Sinha